Tibet Rhodiola Pharmaceutical Holding Co

SHG:600211 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.92 Billion
CN¥14.12 Billion CNY
Market Cap Rank
#8426 Global
#1597 in China
Share Price
CN¥43.81
Change (1 day)
+4.16%
52-Week Range
CN¥35.37 - CN¥56.43
All Time High
CN¥165.99
About

Tibet Rhodiola Pharmaceutical Holding Co. manufactures pharmaceuticals in China and internationally. The company offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. It also provides capsules, biological preparations, granules, and film-coating agents for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthr… Read more

Tibet Rhodiola Pharmaceutical Holding Co (600211) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.030x

Based on the latest financial reports, Tibet Rhodiola Pharmaceutical Holding Co (600211) has a cash flow conversion efficiency ratio of 0.030x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.09 Million) by net assets (CN¥3.94 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tibet Rhodiola Pharmaceutical Holding Co - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Tibet Rhodiola Pharmaceutical Holding Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Tibet Rhodiola Pharmaceutical Holding Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Rhodiola Pharmaceutical Holding Co ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Tibet Rhodiola Pharmaceutical Holding Co (1999–2024)

The table below shows the annual cash flow conversion efficiency of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.95 Billion CN¥994.79 Million 0.252x -21.53%
2023-12-31 CN¥3.37 Billion CN¥1.08 Billion 0.321x +16.10%
2022-12-31 CN¥3.03 Billion CN¥837.38 Million 0.276x +99.38%
2021-12-31 CN¥2.65 Billion CN¥366.53 Million 0.139x -16.23%
2020-12-31 CN¥2.59 Billion CN¥428.17 Million 0.165x -17.33%
2019-12-31 CN¥2.45 Billion CN¥489.59 Million 0.200x +56.16%
2018-12-31 CN¥2.26 Billion CN¥289.22 Million 0.128x +186.57%
2017-12-31 CN¥2.05 Billion CN¥91.46 Million 0.045x -88.24%
2016-12-31 CN¥658.19 Million CN¥250.21 Million 0.380x +37.92%
2015-12-31 CN¥485.90 Million CN¥133.93 Million 0.276x +180.74%
2014-12-31 CN¥414.18 Million CN¥-141.40 Million -0.341x -148.81%
2013-12-31 CN¥399.20 Million CN¥279.22 Million 0.699x +379.69%
2012-12-31 CN¥385.44 Million CN¥56.20 Million 0.146x +328.05%
2011-12-31 CN¥354.94 Million CN¥12.09 Million 0.034x +481.16%
2010-12-31 CN¥324.19 Million CN¥1.90 Million 0.006x -90.17%
2009-12-31 CN¥300.00 Million CN¥17.88 Million 0.060x -22.44%
2008-12-31 CN¥279.15 Million CN¥21.46 Million 0.077x +215.24%
2007-12-31 CN¥274.28 Million CN¥-18.30 Million -0.067x -178.61%
2006-12-31 CN¥396.34 Million CN¥33.63 Million 0.085x +76.37%
2005-12-31 CN¥393.25 Million CN¥18.92 Million 0.048x -22.12%
2004-12-31 CN¥435.51 Million CN¥26.90 Million 0.062x -44.44%
2003-12-31 CN¥424.53 Million CN¥47.20 Million 0.111x +41.76%
2002-12-31 CN¥418.85 Million CN¥32.85 Million 0.078x +106.06%
2001-12-31 CN¥406.50 Million CN¥15.47 Million 0.038x -25.49%
2000-12-31 CN¥402.35 Million CN¥20.55 Million 0.051x +786.04%
1999-12-31 CN¥389.71 Million CN¥2.25 Million 0.006x --